CRWS
Crown Crafts, Inc.
CRWS has the edge over F overall, supported by stronger valuation and stronger fundamentals.
F
Ford Motor Company
F has slightly lower modeled downside risk, despite its lower overall score.
CRWS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
CRWS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
CRWS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.2x | $2.43 | — |
| Cheap | 7.2x | $3.39 | +39% |
| Fair | 9.9x | $4.65 | +91% |
| Expensive | 12x | $5.59 | +130% |
Historical ranges are pointers, not guarantees.
CRWS's PE is in its cheap range at 5.2x.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
CRWS Forward outlook
There aren't enough analyst estimates for CRWS to show an outlook.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CRWS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.47 | +$1.41 |
| Q2 2026 | $0.46 | +$1.43 |
| Q1 2026 | $0.17 | +$1.07 |
| Q4 2025 | -$0.89 | -487% |
| Q3 2025 | -$0.94 | -403% |
| Q2 2025 | -$0.97 | -337% |
| Q1 2025 | -$0.90 | -288% |
| Q4 2024 | $0.23 | -52% |
CRWS has the edge over F on earnings quality, reporting a profit while its opponent remains loss making.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
CRWS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19M | -20% |
| Q2 2026 | $16.8M | +8.3% |
| Q1 2026 | $22.4M | -3.7% |
| Q4 2025 | $20.7M | -11% |
| Q3 2025 | $23.7M | -3.1% |
| Q2 2025 | $15.5M | -4.5% |
| Q1 2025 | $23.2M | +2.9% |
| Q4 2024 | $23.4M | -1.9% |
CRWS's revenue has slid since its 2022 peak: $19M last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.4 points |
| Q2 2026 | 17% | +24 points |
| Q1 2026 | 2.4% | +63 points |
| Q4 2025 | -0.5% | -7.8 points |
| Q3 2025 | 7.9% | +1.7 points |
| Q2 2025 | -7.8% | -5.9 points |
| Q1 2025 | -61% | -67 points |
| Q4 2024 | 7.3% | -2.5 points |
CRWS has the edge over F on profitability, with a higher operating margin.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F has the edge over CRWS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F's operating margin was 2.9% last quarter, about level with the same quarter a year ago.
CRWS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.4M | +$6.4M |
| Q2 2026 | $5.4M | +3.7% |
| Q1 2026 | $926K | -65% |
| Q4 2025 | $2.3M | +$2.6M |
| Q3 2025 | -$1M | +$155K |
| Q2 2025 | $5.2M | -33% |
| Q1 2025 | $2.6M | -8.5% |
| Q4 2024 | -$220K | +$451K |
CRWS generated $14M in free cash flow over the past year, up 115% from the year before.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F still generates free cash flow, though less than at its 2020 peak: $5.1B over the past year.
CRWS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +55K shares |
| 1 year | +1.7% | +181K shares |
| 3 years | +6% | +614K shares |
| 5 years | +7.1% | +721K shares |
| Available history | +6.3% | +638K shares |
CRWS has 11M diluted shares, up 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $18,000 |
| Q4 2022 | — |
| Q3 2022 | $27,000 |
| Q2 2022 | $162,000 |
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has the edge over CRWS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
CRWS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 5.3x | High |
| Q4 2024 | 3.5x | Elevated |
| Q3 2024 | 3.0x | Elevated |
| Q2 2024 | 0.1x | Very low |
| Q1 2024 | 0.9x | Very low |
| Q4 2023 | 1.2x | Healthy |
CRWS's net debt is less than a year of its operating earnings (EBITDA), down from 3.0 years a year ago.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has the edge over CRWS on leverage, with a lower net debt burden relative to earnings.
CRWS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.8 | Neutral |
| Stochastic | 18.4 | Oversold |
CRWS's weekly RSI is 34 (neutral) and its Stochastic is 18 (oversold).
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
CRWS PE vs Consumer Cyclical Sector
| Metric | CRWS | Sector median | Relative |
|---|---|---|---|
| PE | 5.2x | 18x | 71% below |
| PE % | 0 | 47 | 47 pts below |
CRWS is trading at 5.2x earnings, a 71% discount to the Consumer Cyclical sector's median of 18x.
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
CRWS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.44 | 0.4% below |
| 20 week MA | $2.70 | 10% below |
| 50 week MA | $2.76 | 12% below |
| 100 week MA | $3.05 | 20% below |
| 200 week MA | $4.06 | 40% below |
CRWS is in a downtrend: it's below all five of its weekly moving averages, and 40% below its 200-week average.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
CRWS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.10 | $7.15 | +17% |
| 2021 | $7.15 | $7.04 | -1.5% |
| 2022 | $7.04 | $5.30 | -25% |
| 2023 | $5.30 | $4.96 | -6.4% |
| 2024 | $4.96 | $4.51 | -9.1% |
| 2025 | $4.51 | $2.67 | -41% |
| 2026 YTD | $2.67 | $2.43 | -9% |
CRWS has the edge over F on returns for 2026, with the stronger performance.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F's yearly returns have swung widely, from +129% in 2021 to −44% in 2022. It's down 11% so far in 2026.